In CRC cell lines, Kim et al. (2019) found that non-cytotoxic doses of DADS boosted tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-related cell death. The gene discussed is TNFSF10; the disease is colorectal carcinoma.